This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The US Food and Drug Administration (FDA) has granted Fast Track designation for Pfizer and BioNTech’s messenger ribonucleic acid (mRNA)-based combination vaccine candidate against Covid-19 and influenza. The vaccine is intended to prevent two respiratory ailments through a single injection. 5 Omicron sublineages spike proteins.
The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly. With the emergence of vaccines came accusations of technology encroachment amongst biotech companies. Pfizer/BioNTech then countersued in December 2022. But the case will now be investigated by the Eastern District of Virginia.
As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.
Gritstone bio has reported interim results from an ongoing Phase 1 study evaluating the company’s self-amplifying mRNA (samRNA) vaccine as a boost against Covid-19 (CORAL-BOOST). These results were first reported by Gritstone in October 2022. According to GlobalData , there are over 800 Covid-19 vaccines in the pipeline, 42.6%
million government grant from the Flanders Innovation & Entrepreneurship (VLAIO) agency that will be used to fuel the company’s vaccine platform, per a 30 May announcement. This follows a past €30 million seed capital round that was announced in August 2022. AstriVax has received a €2.5
Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.
Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.
Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022. This is likely something we will be living with until we crack the code on how to vaccinate the unvaccinated, and even then we’re all likely to be getting boosters for a long-time.
RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. per 100,000 people were hospitalised for RSV-related reasons in the 2022–23 RSV season. per 100,000.
According to Reuters , Kenya, Tanzania, Senegal and Cameroon have either run out of or are close to running out of vaccines to protect children against the deadly rotavirus infection following undisclosed “manufacturing challenges” at GSK. We are witnessing the largest sustained drop in childhood immunisation in a generation.
On October 7 th , 2022 the U.S. b) Marketing and Communications Oversight. Medicare beneficiaries will be secured by CMS’s finalization of revisions to marketing and communications regulations that will guarantee they get accurate and understandable information about their coverage. Road Towards Approval.
Incidents such as the hormone replacement therapy drug shortage in early 2022 have shown the damaging impact supply chain issues can have on people who depend on these drugs. Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication.
With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. CEVEC became part of Cytiva in October 2022.
Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. Due to the cessation of Russian gas imports following its invasion of Ukraine, electricity prices increased up to tenfold, and raw material costs rose by 50% to 160% in Q3 2022.
Meanwhile, Prescript Communications – which had designed Novartis’ Kesimpta Digital Training Portal, the Bronze winner of the Internal Communications category – said that the company itself had been fortunate to undergo its own creative digitalisation makeover process before being approached for the project, having foreseen developing trends.
According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines.
Towards the conclusion of 2021 many societies announced another shift in format; 2022 conferences would be hybrid, or increasingly and more realistically described as ‘physical with virtual participation options,’ or similar. Part 2 will assess possible scenarios for 2022 and beyond. yes, if vaccines are available; 15.8%
2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward. Wed, 11/02/2022 - 07:32. 2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward. 2 November 2022. Pfizer “cleared runway to allow for large-scale vaccine manufacturing before we had a product!” iSpeak Blog.
Wed, 10/26/2022 - 15:13. November / December 2022. 1 November 2022. It seems like yesterday, and now the 2022 ISPE Annual Meeting & Expo in Orlando, Florida, has come and gone, and Mike Rutherford is the 2022–2023 Chair. Message from the Chair an Exciting Year. Trudy Patterson. Jörg Zimmermann.
He pointed out that the most recently developed MRAs were established between the EMA and the FDA and include inspections for veterinary products, vaccines, and plasma-derived products. The pilot, aimed at evaluating the impact of reliance on PIC/s authorities for GMP verification, began in October 2022 and will be completed in December 2023.
But these boom years gave way to retrenchment in 2022 as investors balked at rising inflation and supply chain pressures. In the fourth quarter of 2022, the most recent period for which data is available, GlobalData estimates suggest the value of venture capital investment in pharmaceutical firms worldwide was $7.8 Source: GlobalData.
2022 Evidence & Opportunity: Impact of Life Sciences in North Carolina.” Published November 2022. AAV gene therapy plant in 2022. Published 15 November 2022. Best places to Live in the US in 2022-2023.” 1 TEConomy Partners. NC Biotechnology Center. link] 3 International Society for Pharmaceutical Engineering.
To ensure people in LMICs have access to new and innovative medicines and vaccines as soon as possible after launch, companies need to have an access plan in place for products in the pipeline from at least Phase II of R&D. 2022 Access to Medicine Index findings. 2022 Access to Medicine Index findings.
Mon, 08/29/2022 - 15:46. September / October 2022. 1 September 2022. HC is expected to have full implementation of ICH Q12 by late 2022. Reader note: This article was initially submitted to Pharmaceutical Engineering® during December 2021/January 2022. Streamlining Postapproval Submissions Using ICH Q12 & SCDM.
Thu, 10/27/2022 - 10:14. November / December 2022. 1 November 2022. AAV vectors are commonly associated with in-vivo gene therapies; AdV vectors show promise for vaccine applications including oncolytic virotherapy; and LV vectors are commonly associated with such ex-vivo approaches as CAR-T cell therapy. Trudy Patterson.
The FDA approved Adstiladrin for the treatment of high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors in adult patients in December 2022. The company aims to then increase supplies in 2024.
Trend #1: Media and Tech: Facilitating Communication. The use of artificial intelligence and machine learning will also increase in 2021 and is expected to become an $8 billion industry by 2022. For example, people mistrust the efficiency and safety of the COVID-19 vaccine.
Processes are in place to check on the impact on MRAs with the need to communicate with partners and evaluate at national level. Conocchia explained that discussions were being held to extend the EU - US MRA to include veterinary products as well as vaccines and blood products. In summary, companies should communicate.
Half a million people in the UK with conditions like blood cancer that prevents them being protected from COVID-19 vaccines are facing another winter shielding, because the government has shelved plans to offer treatment with AstraZeneca’s antibody therapy Evusheld. — Kidney Care UK (@kidneycareuk) August 12, 2022.
Read on for key stories from this year’s Frontiers Health conference in Italy, unlocking the promise of patient support programmes in oncology, supercharging communications with modular content, and much more. Frontiers Health 2022. Create, approve, deploy: supercharging communications with modular content.
a clinical pharmacist at Walgreens in McKinney, Texas, and a 2022 Best of the Best Pharmacy Awards winner. Department of Health & Human Services (HHS) expanded pharmacy technicians roles to include administering vaccines and point-of-care testing during the COVID-19 pandemic.
Marjo Loisa, the director of communications at THL, told the newspaper that “90% of tweets related to the coronavirus are highly inappropriate, and people are joining other discussions with disinformation as well.” million accounts were challenged and 97,674 pieces of global content removed up to September 2022.
Mon, 08/29/2022 - 20:53. September / October 2022. 1 September 2022. The use of structured content and data management in CMC regulatory submissions could potentially provide a direct link to proactively manage risks in the supply chain and communicate with regulators. 5 (May 2022): 1232–1244. Trudy Patterson.
Based on the data, the average distress level among pharmacists has decreased compared to previous reports spanning from 2019 to 2022. The strain on pharmacists can lead to errors, as evidenced by a pharmacist who almost administered the wrong vaccine dosage due to workload pressures. It has declined from 3.25 in 2019 to 2.59.
2022 ISPE Annual Meeting: Convergence and Harmonization Support New Therapies. Thu, 11/03/2022 - 13:48. 2022 ISPE Annual Meeting: Convergence and Harmonization Support New Therapies. 3 November 2022. This was successful, he said, and EMA learned that communication is important between regulators. Trudy Patterson.
With countless media stories regarding COVID-19 published over a period of several years, it was obvious that people around the globe were tuned in to every step of the fight against the pandemic, eagerly learning about everything from symptoms to vaccine development. Long-term partners.
The swift development of COVID-19 vaccines was an unprecedented scientific and collaborative achievement by government, regulators, research institutions, and the pharmaceutical industry. The outlook for global growth continues to deteriorate as inflation continues to significantly exceed the target of 2% in most developed markets.
3 (2022):593–607. October 2022. Nature Communications 12, no. Blood 140, supplement 1 (2022):10323–24. PDA Journal of Pharmaceutical Science and Technology 75, no. 1 (2021):48. 3 a b c Algorri, M., Re-Envisioning Pharmaceutical Manufacturing: Increasing Agility for Global Patient Access.” September 2004. Discussion paper.
Wed, 10/26/2022 - 16:08. November / December 2022. 1 November 2022. ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Trudy Patterson.
In March 2022, a UCL-based team from the MRC Prion Unit and Institute of Prion Diseases shared findings from a Phase I study that tested a mAb, PRN100, that they developed, in six patients. According to Mabbott, a challenge with developing mAbs or vaccines is their potential toxicity. Movement in imaging and exploratory therapeutics.
This is an ongoing challenge, and one that reared its head again during the pandemic, as questions over vaccine equity arose. At a more fundamental level, even the words used in scientific communication are facing scrutiny because of how they can affect people’s health outcomes.
In addition, in 2022, non-new molecular entity (NME) injectables approvals were the highest they have been for the last decade. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. In 2022 alone, the company increased FirstLine capacity by 15%.
Nearly 6,000 such trials were underway at the end of Q3 2022, with hundreds more in the pipeline. The global vaccine rollout would never have taken place without the advances in visibility and control over supply chains that it necessitated. The Covid-19 pandemic played a pivotal role in catalysing change.
The global pandemic created an unprecedented demand for vaccines, shut down many clinical trials, and resulted in a worldwide PPE shortage. And now, almost at the end of 2022, the industry is still scrambling to catch up. While the vaccine was being developed, the industry found it difficult to display clinical trial protocols openly.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content